| no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
| 1 |
A molecular view of the function and pharmacology of acid-sensing ion channels
|
Vullo, Sabrina
|
|
|
154 |
C |
p.
|
article
|
| 2 |
Drug-induced endocrine blood pressure elevation
|
Beck, Katharina R.
|
|
|
154 |
C |
p.
|
article
|
| 3 |
Drugs and hepatic transporters: A review
|
Jetter, Alexander
|
|
|
154 |
C |
p.
|
article
|
| 4 |
Editorial Board
|
|
|
|
154 |
C |
p.
|
article
|
| 5 |
Granulocyte death mediated by specific antibodies in intravenous immunoglobulin (IVIG)
|
Graeter, Stefanie
|
|
|
154 |
C |
p.
|
article
|
| 6 |
Harnessing the immune system to fight cancer with Toll-like receptor and RIG-I-like receptor agonists
|
Bourquin, Carole
|
|
|
154 |
C |
p.
|
article
|
| 7 |
Historical account and current research of pharmacology in Switzerland
|
Rüegg, Urs
|
|
|
154 |
C |
p.
|
article
|
| 8 |
Improvements of symptoms of Alzheimer`s disease by inhibition of the angiotensin system
|
Quitterer, Ursula
|
|
|
154 |
C |
p.
|
article
|
| 9 |
Interprofessional and interdisciplinary collaboration for early phase oncological clinical trials in academia—Myo-inositoltrispyrophophate as model
|
Grossmann, Regina
|
|
|
154 |
C |
p.
|
article
|
| 10 |
Introductory letter by the guest editors
|
Rüegg, Urs
|
|
|
154 |
C |
p.
|
article
|
| 11 |
Letter from the Council of the Swiss Society of Pharmacology and Toxicology (SSPT)
|
Traber, Martin
|
|
|
154 |
C |
p.
|
article
|
| 12 |
Mechanisms of statin-associated skeletal muscle-associated symptoms
|
Bouitbir, Jamal
|
|
|
154 |
C |
p.
|
article
|
| 13 |
Optimisation of vancomycin exposure in neonates based on the best level of evidence
|
Dao, Kim
|
|
|
154 |
C |
p.
|
article
|
| 14 |
Optimization for multidrug combinations: Challenges and perspectives in complex disorders
|
Nowak-Sliwinska, Patrycja
|
|
|
154 |
C |
p.
|
article
|
| 15 |
Pharmacological targeting of age-related changes in skeletal muscle tissue
|
Leuchtmann, Aurel B.
|
|
|
154 |
C |
p.
|
article
|
| 16 |
Pharmacology of nerve growth factor and discovery of tanezumab, an anti-nerve growth factor antibody and pain therapeutic
|
Hefti, Franz
|
|
|
154 |
C |
p.
|
article
|
| 17 |
Potential role of the 3-mercaptopyruvate sulfurtransferase (3-MST)—hydrogen sulfide (H2S) pathway in cancer cells
|
Augsburger, Fiona
|
|
|
154 |
C |
p.
|
article
|
| 18 |
Targeting the S1P receptor signaling pathways as a promising approach for treatment of autoimmune and inflammatory diseases
|
Stepanovska, Bisera
|
|
|
154 |
C |
p.
|
article
|
| 19 |
The long and winding road in pharmaceutical development of canakinumab from rare genetic autoinflammatory syndromes to myocardial infarction and cancer
|
Gram, Hermann
|
|
|
154 |
C |
p.
|
article
|
Journal description